A systematic review of health economic models of opioid agonist therapies in maintenance treatment of non-prescription opioid dependence.

CONCLUSION: A relatively small number of studies of varying quality were found. Strengths and weaknesses relating to model structure, inputs and approach were identified across all the studies. There was no indication of a single standard emerging as a preferred approach. Most studies omitted societal costs, an important issue since the implications of drug abuse extend widely beyond healthcare services. Nevertheless, elements from previous models could together form a framework for future economic evaluations in opioid agonist therapy including all relevant costs and outcomes. This could more adequately support decision-making and policy development for treatment of non-prescription opioid dependence. PMID: 28235415 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/28235415?dopt=Abstract

Source: Addiction Science and Clinical Practice - February 23, 2017 Category: Addiction Authors: Chetty M, Kenworthy JJ, Langham S, Walker A, Dunlop WC Tags: Addict Sci Clin Pract Source Type: research